Project facts sheet

Abstract

Endocrine medicine is entering a digital era. Data, technology, and personalised treatments offer more precise and accessible care.

However, progress is slow due to a shortage of experts who can connect clinical practice with data science.

Supported by the Marie Skłodowska-Curie Actions programme, the ENDOTRAIN project aims to train doctoral candidates from eight countries in interdisciplinary digital endocrine medicine.

Specifically, it will combine expertise from different fields and help researchers translate complex academic findings into practical healthcare solutions.

These skilled scientists and clinicians will foster innovation in endocrine care and beyond. They will enhance Europe’s ability to lead in digital medicine, while addressing the ethical, legal, and technological challenges of this rapidly changing field.

Objectives

Digital endocrine medicine is revolutionizing healthcare by integrating technology, data, and personalized treatment, enabling more precise, efficient, and accessible care that disrupts traditional medical models.

Advancing digital endocrine medicine to the next level of knowledge and translational value demands an ‘integrative’ approach that departs from the conventional ‘sum of monothematic experts’ towards the ‘merging of multiple themes in one expert’.

In this fast developing field, interdisciplinary experts can better communicate across topics as dispersed as clinical medicine, data science (incl. machine learning and artificial intelligence), mathematics, engineering, biochemistry, biotechnology, ethics, law, while adapting academic findings to real word needs.

ENDOTRAIN is poised to fill in the gap of interdisciplinary experts needed to advance digital endocrine medicine research and clinical application.

This doctoral network joins leading researchers and entrepreneurs from 8 countries to train 15 Doctoral Candidates (DCs), along with 4 DCs funded by Switzerland (SDCs), across different disciplines and sectors.

Exceptionally trained in digital endocrine medicine, these versatile DCs will be prepared to face broader challenges beyond endocrinology and become the next generation of clinicians, scientists, and innovators, equipped to enhance Europe’s capacity to navigate the rapidly evolving landscape of digital medicine.

Consortium

Member institutions

• University of Bergen, Norway (UiB)
• Ludwig-Maximilians-Universität München, Germany (LMU)
• Evangelismos Hospital, Greece (EvH)
• University of Bristol, UK (UNIBRI)
• Karolinska Institutet, Sweden (KI)
• Imperial College London, UK (ICL)
• Adhera Health SLU, Spain (Adhera)
• University of Manchester, UK
• University of Birmingham, UK (UoMB)
• University of Ulm, Germany (UULM)
• Sapienza Università di Roma, Italy (UNIROMA1)
• University of Reading, UK (UoR)
• Université Côte d’Azur, France (UniCA)

Associated partners

• Universitätsspital Zürich
• ETH Zurich
• Leitwert AG
• Rarity Bioscience
• Dynamic Therapeutics
• Performacare
• EIT Digital
• National and Kapodistrian University of Athens

---

Open Ph.D. positions at the RAISE Lab